Capricor Therapeutics
CAPR
#5195
Rank
C$2.30 B
Marketcap
C$39.86
Share price
-2.40%
Change (1 day)
176.87%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -C$0.15 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -C$55.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -C$0.15 Billion159.57%
2024 -C$55.88 Million81.57%
2023 -C$30.78 Million-23.2%
2022 -C$40.07 Million44.93%
2021 -C$27.65 Million46.61%
2020 -C$18.86 Million78.71%
2019 -C$10.56 Million-49.7%
2018 -C$20.98 Million-724.78%
2017 C$3.35 M-112.93%
2016 -C$25.97 Million46.27%
2015 -C$17.76 Million106.82%
2014 -C$8.59 Million-48.41%
2013 -C$16.64 Million977.23%
2012 -C$1.55 Million-77.11%
2011 -C$6.75 Million-22.35%
2010 -C$8.69 Million-20.17%
2009 -C$10.89 Million-41.17%
2008 -C$18.51 Million41.05%
2007 -C$13.12 Million1098.87%
2006 -C$1.1 Million4101.55%
2005 -C$0.03 Million-0.97%
2004 -C$0.03 Million17.87%
2003 -C$0.03 Million3.66%
2002 -C$0.03 Million-30.11%
2001 -C$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.86 B-24,832.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$1.10 B-860.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-C$1.15 Billion 689.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.4 Billion 173.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-C$6.63 Million-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$13.11 Million-90.97%๐Ÿ‡บ๐Ÿ‡ธ USA